Next Article in Journal
Aspergillus fumigatus, One Uninucleate Species with Disparate Offspring
Next Article in Special Issue
Detection and Control of Dermatophytosis in Wild European Hedgehogs (Erinaceus europaeus) Admitted to a French Wildlife Rehabilitation Centre
Previous Article in Journal
Trends on Aspergillus Epidemiology—Perspectives from a National Reference Laboratory Surveillance Program
Previous Article in Special Issue
Landscape Connectivity Limits the Predicted Impact of Fungal Pathogen Invasion
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cryptococcus in Wildlife and Free-Living Mammals

by
Patrizia Danesi
1,*,
Christian Falcaro
1,
Laura J. Schmertmann
2,
Luisa Helena Monteiro de Miranda
2,
Mark Krockenberger
2 and
Richard Malik
3
1
Laboratory of Parasitology, Istituto Zooprofilattico Sperimentale delle Venezie, 35020 Legnaro, Padua, Italy
2
Veterinary Pathology Diagnostic Services, Sydney School of Veterinary Science, The University of Sydney, Sydney 2006, Australia
3
Centre for Veterinary Education, The University of Sydney, Sydney 2006, Australia
*
Author to whom correspondence should be addressed.
J. Fungi 2021, 7(1), 29; https://doi.org/10.3390/jof7010029
Submission received: 20 November 2020 / Revised: 22 December 2020 / Accepted: 1 January 2021 / Published: 6 January 2021
(This article belongs to the Special Issue Mycoses in Wildlife)

Abstract

:
Cryptococcosis is typically a sporadic disease that affects a broad range of animal species globally. Disease is a consequence of infection with members of the Cryptococcus neoformans or Cryptococcus gattii species complexes. Although cryptococcosis in many domestic animals has been relatively well-characterized, free-living wildlife animal species are often neglected in the literature outside of occasional case reports. This review summarizes the clinical presentation, pathological findings and potential underlying causes of cryptococcosis in various other animals, including terrestrial wildlife species and marine mammals. The evaluation of the available literature supports the hypothesis that anatomy (particularly of the respiratory tract), behavior and environmental exposures of animals play vital roles in the outcome of host–pathogen–environment interactions resulting in different clinical scenarios. Key examples range from koalas, which exhibit primarily C. gattii species complex disease presumably due to their behavior and environmental exposure to eucalypts, to cetaceans, which show predominantly pulmonary lesions due to their unique respiratory anatomy. Understanding the factors at play in each clinical scenario is a powerful investigative tool, as wildlife species may act as disease sentinels.

1. Introduction

Cryptococcosis in wildlife and domesticated ungulates has been well reported but has not been systematically reviewed. This paper aims to correct this deficiency in the literature, focusing on free-living wild animals and those kept in captivity. A separate publication will focus on cryptococcosis in production animals (sheep, goats, camelids) and horses. Cryptococcosis is usually a sporadic disease in individual animals. Occasionally several animals are affected at the same time in the same place. Overall, it is an uncommon problem throughout the world. As an entity, it is more common under certain geographical conditions, e.g., in certain parts of Australia, Brazil and the Pacific North West of Canada and the United States of America (USA). The range of animals susceptible to infection is extraordinarily wide—from single-celled Acanthamoeba to large marine mammals. This includes a wide diversity of wildlife species, small companion animals, horses, production animals and human patients. In addition to koalas and companion animals (cats, dogs, ferrets), cryptococcosis has been described both as a cause of clinical disease, subclinical infection and/or asymptomatic mucosal colonization in many terrestrial and aquatic placental mammals, including marsupials, monotremes, birds, reptiles, amphibia and fish.
The overall pattern of cryptococcosis in wildlife species is complicated. Clinical and investigative findings from populations of wild animals are disparate and scattered over many different journals, with few systematic studies of large numbers of cases, so the challenge is to develop a conceptual framework that allows these observations to contribute to our understanding of this disease in all species. The fragmentary nature of the existing literature ranges from single case reports due to opportunistic necropsy examinations after accidental death, to more detailed case studies of patients living in artificial captive environments (e.g., koalas in captivity in Australia, USA, Spain and Japan) or involved in outbreak events (e.g., in Vancouver Island and nearby British Columbia; epizootics affecting goats in Spain). Complicating this fragmented literature, the accuracy of pathogen identification is influenced by which diagnostic specimens were collected and by the variable application of available laboratory tools (i.e., cytology, histopathology, culture, MALDI-TOF MS, multilocus sequence typing (MLST) and whole-genome sequencing), but also by taxonomic reassessment of the pathogens over time. The Cryptococcus neoformans and C. gattii species complexes are the most important causes of cryptococcosis in wildlife, with higher prevalence in animals from endemic areas (Western Canada, Australia and Brazil), and especially in koalas, an arboreal marsupial which live in eucalypt trees strongly associated with C. gattii.
Additional epidemiologic information is afforded by the systematic monitoring of many wild and synanthropic animal populations, usually performed at the same time as other public health actions (e.g., avian influenza surveillance in birds and culling of an overabundant pest species) or animal management programs (e.g., annual health checks of vulnerable animal populations). In general, results from studies of this type suggest that wild animals are more likely to have subclinical disease (i.e., infection without overt signs) than to be clinically affected by cryptococcosis [1,2].
This review aims to summarize information about cryptococcosis in wild animals including feral ungulates, terrestrial species and marine mammals which have in common a ”free-living lifestyle”. Therefore, we have included reports concerning animals living in undomesticated settings (i.e., wild animals) in their natural environment, animals living in a confined area such as zoological parks (e.g., koalas, marine mammals, large felids) and, briefly, ungulates living in an open range environment.

2. Nomenclature

The nomenclature of C. neoformans and C. gattii species complexes remains controversial and has the potential to be confusing, as there have been numerous taxonomic changes over the past 40 years and the taxonomy continues to be in a state of flux, with two distinct taxonomic ”camps” [3].
Historically, pathogenic Cryptococcus isolates were treated as a single species (C. neoformans) for more than a century [4]. Heterogeneity among isolates became increasingly apparent from the 1960s and led to the recognition of four serotypes (A, B, C, D) based on capsular polysaccharide epitopes [5]. The discovery of two different teleomorphs, Filobasidiella neoformans (anamorph; Cryptococcus neoformans) and Filobasidiella bacillospora (anamorph; Cryptococcus gattii) [6,7], confirmed a division of the previously recognized single species, and this taxonomic revision was later verified by whole-genome sequencing studies [8]. Thus, in 2002, isolates belonging to serotypes B and C were formally classified as C. gattii [9], while C. neoformans encompassed all serotype A, AD and D strains [10].
Over the last 20 years or so, population structure analysis of the two species using molecular typing methods, including PCR fingerprinting [11], amplified fragment length polymorphism (AFLP) analysis [12], multilocus sequencing MLST [13] and whole-genome sequencing [14,15], has demonstrated that C. neoformans and C. gattii isolates both comprise multiple genetically diverse monophyletic clades [16,17]. A recent proposal was made to designate seven MLST clades identified among C. neoformans and C. gattii into new species: C. neoformans into two species and C. gattii into five species (Figure 1) [18]. To date, the newly proposed nomenclature has not achieved acceptance within the scientific community (debated at the 10th International Conference on Cryptococcus and Cryptococcosis in Brazil, 2017), due to unclear biological differences amongst the lineages and a lack of clear consensus concerning the limits and numbers of putative species boundaries. In order to avoid confusion, in this review, we refer to ”Cryptococcus neoformans species complex” and ”Cryptococcus gattii species complex” to identify these fungal pathogens, terms that are well understood and accepted amongst mycologists, veterinarians and physicians, while consensus of further species delineation is achieved, although there remains uneven adoption of the proposed taxonomic nomenclature resulting in unwarranted confusion in the literature [3].
To make reading this manuscript simpler, we will use anamorph names and molecular types as reported in Figure 1.

3. Epidemiology

Members of the C. neoformans species complex and members of the C. gattii species complex are both globally distributed, although there are important differences in their environmental associations and with their specific geographical preferences [19].
C. neoformans tends to be widely distributed throughout the environment, and although tree and plant associations are documented throughout the world, traditionally, the strongest environmental magnifier is aged dried avian guano accumulations protected from light (particularly pigeon excreta) [20].
C. gattii has tended to have a much more restricted geographic distribution than C. neoformans, causing human disease in temperate to tropical climates in Australia, Papua New Guinea, South-East Asia, the Indian subcontinent, parts of Africa, Mexico, Brazil, Paraguay and California. The global distribution of C. gattii has been related to tectonic plate movements [21,22].
The first environmental isolation of C. gattii was made by David Ellis and Tania Pfeiffer, in the Barossa Valley of South Australia. These investigators established the remarkably specific ecological association with Eucalyptus camaldulensis (river redgum), widely distributed along rivers in mainland Eastern Australia. The global distribution of C. gattii was long thought to reflect the global distribution of eucalypt natural habitat and forestry operations; however, recently, carob and olive trees were suggested as additional important environmental niches for C. gattii strains in the Mediterranean basin [23].
Unlike C. neoformans, other Cryptococcus species, including C. uniguttulatus, C. albidus and Papiliotrema laurentii (formerly Cryptococcus laurentii), are commonly isolated from excreta and cloacal swabs from feral pigeons (Columba livia) and birds of Charadriiformes, Anseriformes and Gruiformes orders [2,24,25]. Worldwide, plant and animal associations play a key role in the epidemiology of cryptococcosis [26,27]. A substantial difference exists between the C. neoformans and C. gattii species complex [21]. Although isolates of C. neoformans species complex occur more commonly in immunosuppressed human patients than isolates of the C. gattii species complex [28], each can cause disease in apparently immune competent humans and other animals [29].
Within the C. neoformans species complex, C. neoformans VNI is most common amongst both human and companion animal patients (dogs, cats, ferrets). In contrast, VNII is rarer, associated with higher morbidity and has an association with HIV-positive human patients. In companion animals, the consensus view is that any association of cryptococcosis caused by C. neoformans with reduced immune status is weak [29], although there is some suggestion of an impact of retroviral status and genomic predispositions on disease outcomes in cats, with an increased likelihood of severe cryptococcosis in cats infected by feline leukemia virus and/or feline immunodeficiency virus [30] and higher prevalence and more severe and refractory disease in Ragdoll and Birman breeds.

4. Pathogenesis and Virulence Factors

Important virulence factors of the C. neoformans and C. gattii species complexes include (i) the formation of a thick polysaccharide capsule to avoid and suppress the host immune response, (ii) capacity to grow at mammalian body temperature, (iii) production of melanin by laccase to resist host and environmental free radicals, (iv) production of urease and phospholipase B to facilitate tissue invasion, (v) production of superoxide dismutase and trehalose to evade the host immune response and (vi) development of polyploid ”titan cells” to further resist phagocytosis [31]. These virulence factors are also important features for environmental survival, including survival within soil amoeba, and evolution has favored the development of features which permit survival in the environment, which also facilitate survival in mammalian hosts [32].
The evolution of virulence in Cryptococcus and various other mycotic pathogens may have been driven by interactions and predation by free living amoeba species such as Acanthamoeba castellanii. This proposed evolutionary process has been put forward as the ”amoeboid predator-fungal animal virulence” hypothesis [33]. Since the 1950s, it has been known that A. castellanii feeds voraciously on C. neoformans [34]. The cryptococcal polysaccharide capsule, melanin synthesis and phospholipase have each been shown to be essential for C. neoformans to resist predation by A. castellanii, and C. neoformans responds to both A. castellanii and mammalian macrophages by enlarging, triggered by expression of phospholipase-B [35].
Because the Cryptococcus species complexes are present ubiquitously in the environment, exposure typically occurs early in life, presumably through inhalation of spores or desiccated yeast cells. Such exposure is typically asymptomatic, as the fungus is either cleared, colonizes the respiratory or alimentary tract transiently or becomes dormant [36]. In immunosuppressed individuals, however, fungi can reactivate and disseminate hematogenously from the lungs and the hilar lymph nodes. Although this pathogen can affect virtually any tissue, it has a striking tropism for the central nervous system (CNS), causing meningoencephalitis that is fatal, without treatment [37], with similar predilection for neural ocular tissues.
Many critical fungal pathogens of plants, animals and humans can switch between a unicellular yeast morphology and a multicellular hyphal form. Such morphological transitions are associated with an ability to infect, invade, evade and disseminate widely. Like other dimorphic pathogens acquired from the environment, such as Histoplasma, Blastomyces and Coccidioides, Cryptococcus species complexes are found as a yeast form in host tissues [38] (Figure 2). Variations in cryptococcal life cycle and the associated cellular adaptions profoundly influence cryptococcal pathogenesis [39]. Firstly, different morphotypes elicit distinct host responses [40]. Secondly, sexual and asexual cycles generate infectious basidiospores that can penetrate deeply into the bronchial tree [41,42]. Finally, the phenotypic and genotypic diversity referable to sexual reproduction increases cryptococcal fitness and adaptability [42,43,44].

5. A Possible Environmental Niche

Although C. neoformans species complex fungi are often associated with pigeon guano, birds are most unlikely to be the major source of cryptococci in the natural world, since only low C. neoformans prevalence, ranging from 0 to 2.2%, was found in samples from crop, feet and cloacal swab of Columbiformes and water birds in Italy, Sweden, Czech republic and Iran [2,25,45,46]. Most likely, Cryptococcus propagules from the environment are deposited onto the nitrogen-rich guano where they grow, rather than being transferred to it through a passage along the alimentary tract of the bird. Indeed, the core body temperature of birds is as high as 42–44 °C, which is inhibitory to cryptococcal growth and multiplication; the high ammonia concentrations in fresh droppings are also inhibitory to growth. It is of great interest that C. neoformans can complete its life cycle, including mating, on pigeon guano although C. gattii complex fungi do not. Thus, it seems quite possible that pigeon guano could represent the definitive ecological niche of C. neoformans [47]. In contrast, no specific strong association with bird, animal or insect vectors has been established.
The C. gattii species complex (mainly VGI) was well known as an important pathogen of Australian wildlife, although its close relative C. gattii VGII also proved to be an important cause of disease of wildlife on Vancouver Island and the Pacific Northwest, while most recently, an association between C. gattii VGV and the African hyrax has been shown in Zambia. C. gattii VGI is the most geographically widespread member of this species complex in Australia [28], and it is by far the most common cause of cryptococcosis in Australian wildlife [48]. This is most likely because of the strong association of VGI with Eucalyptus spp. trees [43].
A C. gattii VGII outbreak that began in 1999 on Vancouver Island, and subsequently became endemic, caused numerous human and animal infections. Furthermore, the pathogen spread to the nearby mainland of British Columbia. Since 2006, the molecular type VGIIc emerged in human and veterinary cases in Washington and Oregon in the Pacific Northwest of the USA [49]. Over the 1999–2003 period, there was a progressive increase in the annual occurrence of animal cases diagnosed, while human cases plateaued in later years. Critically, there were approximately 75% more animal cases than human patients, and often in atypical animal species, such as horses, ferrets and marine mammals (rather than just cats and the occasional dog). This is despite the fact that in all likelihood, animal cases were more likely to go undiagnosed or unreported compared to humans [50]. Animal cryptococcosis cases had been identified on Vancouver Island prior to 1999 but at a much lower prevalence. Therefore, the suggestion is that the organism emerged in the region prior to its identification as a causative agent for human disease. These findings imply that animals, by virtue of (i) increased case numbers, (ii) emergence in unusual species and, potentially, (iii) a shorter incubation period, may serve as outstanding sentinels for human cryptococcosis. Their role in establishing the emergence of C. gattii in Canada should receive greater emphasis [51,52] as should the contribution of the local veterinary pathologist, Dr Sally Lester, whose diagnostic observations resulted in a timely appreciation of the outbreak.
In 2019, the first isolates representing the VGV lineage were recovered, together with VGI and VGII isolates from middens, midden soil and tree holes of the southern tree hyrax (Dendrohyrax arboreus) [53]. While C. gattii has not yet been demonstrated to pass through the alimentary tract of mammals, associations with small mammals such as hyrax suggest a potential evolutionary mechanism to generate adaptations that confer pathogenicity—a notion recently posited as the “endozoan, small-mammal reservoir hypothesis” [54]. This concept deserves to be further explored.
The southern tree hyrax is a small herbivore, counterintuitively closely related to the elephant. Hyraxes defecate in communal latrines situated in the crevices of rocky kopjes. These sites are used over numerous generations [55], being located in sheltered rocky caves where droppings are likely to accumulate for periods of upwards of 50,000 years forming middens of stable paleoenvironmental urea-rich nitrogenous material containing an unprecedented richness of paleoclimatic proxies [56]. Cryptococcus species complexes fungi have a marked tropism for urea as a nutrient substrate, including pigeon guano, which is known to support the prolific growth of C. neoformans and to a lesser extent C. gattii [47]. The finding that hyrax middens are hotspots of Cryptococcus diversity (including VGI, VGII and VGV from sampling in Zambia) suggests that their ecological stability in regions rich in nitrogen availability will result in them being vital crucibles for cryptococcal evolution. Studying these environments will likely provide a fertile ground for further discovery of diversity within this genus [27].

6. Wild Mammals

6.1. Cryptococcosis in Wild Felids

Among wild felids, cryptococcosis is described only in cheetahs. Most of the cases have been recorded from South Africa. Only a single case was described from Cuba in a cheetah following reactivation of infection probably acquired 16 months earlier, at the time the animal was moved from South Africa [57]. Clinical signs described in cheetahs included hind limb lameness [58], a skin mass overlying the zygomatic arch with enlargement of ipsilateral regional lymph node [59] and generalized weakness. Neurological signs described in cheetahs with cryptococcosis include incoordination and change in behavior, and ataxia in all four limbs [59,60]. (Figure 3, Table 1).
Most animals showed concurrent pulmonary and CNS signs [58,59,60]. Inhalation of airborne organisms with subsequent hematogenous or lymphatic spread was the most likely route for cryptococcal infection. The pulmonary cryptococcoma present in these cheetahs provides strong circumstantial evidence for this theory. Interestingly, in this species, the upper respiratory tract is spared, suggesting the deep inhalation during and after exertion, with deep tidal volumes, might facilitate deposition of infective propagules deep into the bronchial tree. Cryptococci from the lungs spread to the CNS, either hematogenously or by local extension through the cribriform plate (in rare cases of sinonasal infection). In the absence of apparent upper respiratory disease in these cheetahs, it is likely that dissemination was typically hematogenous from primary lung lesions [58,59,60]. These animals were seronegative for FeLV, FIV, feline coronavirus and paramyxovirus.
Of great interest was the case of C. gattii VGI described in Cuba from a cheetah imported 16 months earlier from South Africa [57,61]. The authors posit that the animal had a dormant infection at the time of translocation to the zoo in Cuba. Considering the accepted notion that there is a regional correlation between environmental and clinical isolates [64], there is no evidence whatsoever for C. gattii isolates in Cuba from clinical and environmental samples, despite an extensive search [65].
Even though cryptococcosis is the most common systemic mycotic disease described in felids, observations from other species suggest that subclinical infection with spontaneous elimination of cryptococci is probably much more common than clinical infection. Factors favoring progression to disease have been linked with the presence of comorbidities or other immune-suppressive conditions. In domestic cats, there is anecdotal evidence for genetic susceptibility to cryptococcosis [66]. The cheetah can be considered to be conceptually akin to particular pedigree cat breeds in terms of vulnerability to certain infectious diseases because the entire species lacks heterogeneity at MHC loci encoding peptides mediating immune responsiveness to pathogens [58,67]. Other studies have reached a different conclusion, namely, that immune status in cheetahs depends on mechanisms not solely related to their lack of genetic diversity [67].
A common necropsy finding in captive cheetahs is diffuse adrenocortical hyperplasia. This change has been described in many other captive wild animals [68,69,70]. For example, the extent of adrenocortical hyperplasia has been correlated to the stress of captivity in nine-banded armadillos, the platypus and harbor porpoises [68,69,71]. High blood cortisol concentrations occur in animals with diffuse adrenocortical hyperplasia and this, together with the well-known depression of monocyte function by cortisol, may go some way to explain the predisposition of the captive cheetah to develop cryptococcosis when kept under stressful conditions.
In addition, lymphocytic depletion of the spleen has also been observed in some captive cheetah cases [70]. These immunosuppressive effects would be enhanced by the polysaccharide capsule of C. neoformans, which inhibits phagocytosis, plasma cell function and leukocyte migration [59,62,63]. Along with domestic felids, adult male cheetahs appear to have the highest incidence of cryptococcosis amongst the Felidae [58,59,60].

6.2. Cryptococcosis in Koalas

Cryptococcosis occurs sporadically in a broad range of Australian native mammals. There is a preponderance of respiratory and neurological presentations amongst these cases, with tracheobronchial pneumonia and sinonasal disease also being common. Disseminated disease and disease affecting other organs or tissues is less frequent, although occasionally infections seem to occur after penetrating injury and can involve subcutaneous tissues and underlying bone [72] (Figure 4). The prevalence in koalas is comparatively high, probably the highest prevalence of any species (3% of koala necropsies are attributable to cryptococcosis), in part because they are commonly held in wildlife parks and zoological gardens where they appear to amplify the presence of C. gattii, both VGI and VGII, in their immediate environment. Additionally, koalas are more commonly intensively studied in wild and captive populations, and they have an intimate association with a common environmental niche of C. gattii VGI, viz. a variety of eucalypt tree species. Consequently, the disease is well recognized and thoroughly characterized in this species [73,74,75].
In koalas, as in most other species, respiratory tract involvement is observed most commonly (78% of cases), with pneumonia (73% of respiratory tract cases) and upper respiratory tract disease both common (48% of respiratory tract cases). A substantial proportion of koalas with upper respiratory tract lesions (mostly sinonasal and nasopharyngeal disease) also have lower respiratory tract involvement (42% of cases with sinonasal disease also have pneumonia). Spread of infection to regional lymph nodes is commonly present (20% of cases), but rarely without additional tissue involvement. Disseminated disease is relatively frequent (34% of cases) and can develop after a longstanding respiratory illness (76% of disseminated cryptococcosis has an identifiable primary focus in the respiratory tract; Figure 2). As in other species, cryptococcosis can be regarded as relatively neurotropic (32% of cases have CNS involvement), but less commonly as the only organ system reportedly involved (14% of koala cryptococcosis cases).
Although cryptococcosis is commonly observed and documented in captive koalas, case clusters in free-ranging populations are being recognized more commonly (39% of cases documented have been reported in free-ranging koalas). There is little evidence to suggest a gender bias of koala cases, with 47% of cases in males and 53% in females. The role of potential immune suppression or association with koala retrovirus variants in the pathogenesis of cryptococcosis remains unclear but intriguing, and the subject of active investigations [76].
For cryptococcosis to develop, contact with the organism is necessary for colonization to occur. Once colonization is established, subclinical or clinical cryptococcosis may then develop. Progression may be rapid or slow, but is not inevitable, and colonization and even subclinical disease may spontaneously resolve over time as a result of effective adaptive immunity. Spontaneous resolution after transient subclinical disease is a common occurrence in young koalas soon after independence.
Most koala cases where the causative agent was definitively identified were attributable to the C. gattii species complex [77], with a single case caused by the C. neoformans species complex in a captive koala in Spain [75]. In most of Australia, especially along the east coast, cryptococcosis is usually caused by C. gattii VGI, although in south-western Western Australia (WA) infections can also involve C. gattii VGII, including cases where koalas have been infected in WA and developed disease following translocation elsewhere within Australia [78].
Colonization, subclinical and clinical cryptococcosis in captive koalas presents a substantial management concern in most koala facilities, especially in relation to translocation of animals, and serological monitoring (using the latex cryptococcal antigen agglutination test or lateral flow assays) is generally recommended as a component of a standard health check at least once or twice a year, and prior to moving koalas to new facilities. Mycological culture of the nasal mucosa may sometimes be added to monitoring programs to understand the degree of environmental contamination and exposure of the resident koalas to the organisms and a predictor of the prevalence of subclinical and clinical cryptococcosis [48].

6.3. Cryptococcosis in Marine Mammals

Marine mammals, which include delphinids (Stenella, Tursiops and Lagenorhynchus species), porpoises (Phocoenoides dalli and P. phocoena), pinnipeds such as harbor seal (Phoca vitulina) and sea lion (Zalophus californianus) and baleen whales such as the southern right whale (Eubalaena australis) are susceptible hosts for various mycoses including cryptococcosis (Table 2). Marine mammals are likely to be at risk for developing infection only when they come sufficiently close to land to be exposed to infective propagules (likely spores) in effluent and run off that is washed into the ocean. Animals with blow holes are especially vulnerable, as they breathe in an enormous tidal volume with marked inspiratory effort following explosive expiration, and without the benefit of filtration of inspired air via sinonasal protective mechanisms. As a result, a large inoculum of infective spores can be carried deep into the lower respiratory tract.
Since around 2000, cryptococcal infections have emerged as causes of disease in both humans and marine mammals living in the vicinity of Vancouver Island and the Pacific Northwest of the USA and Canada. Indeed, most of the 54 marine mammal cases summarized in Table 2 are from the Northwest Pacific region area, except for a spinner dolphin from Hawaii [79], a striped dolphin from Western Australia [80] and a whale neonate from South Africa [81].
During the emergence of C. gattii VGII in British Columbia, 22 juvenile harbor seals (Phoca vitulina) were monitored by using blow hole swabs (19×) and lung culture (3×), tested negative for Cryptococcus spp.
C. gattii was identified in 45/54 cases of symptomatic cryptococcosis (Table 2), C. neoformans in five animals, and the less pathogenic Cryptococcus albidus was reported from a stranded California sea lion (Zalophus californianus) [82]. The Cryptococcus species was not identified in three cases [80,83,84]. C. gattii VGI was genotyped from four delphinids [79,85] and a porpoise [86] and C. gattii VGIIa from three porpoises [85] and a single harbor seal [87].
A common finding in all marine mammal cases was the tropism for the lungs, lymph nodes and gastrointestinal tract, with the lung as the logical portal of entry for infection. Extension of the fungus to the brain was recorded in harbor seal (2 cases) and a harbor porpoise [87,90]. Interestingly, maternal–fetal transmission of C. gattii was described in a porpoise (Phocoena phocoena) [88]. In a single case, there was extension of the fungus into the stomach, adrenal glands, kidneys and spleen [79]. In the single case of whale neonate from South Africa, skin lesions were culture-positive for Candida zeylanoides but not for C. neoformans, which was identified only by PCR. Considering all marine mammal infections, porpoises (39) and dolphins (9) were the most common species infected.
It should be stated, however, that there could be some bias in the observational data, if we just consider the reported fungal cases in Table 2 as a true reflection of fungal diseases in marine mammals. Importantly, investigators have commented there is little doubt we are observing a more substantial number of cases in animals maintained in artificial vs. natural water systems.

6.4. Cryptococcosis in Free-Living Ungulates

Among wild ungulates, only two cryptococcosis cases have been reported. The most recent case was a yearling white-tailed deer (Odocoileus virginianus) living in Nova Scotia, Canada [91]. This deer was found in the village of Greenwood in July 2014, exhibiting behavioral and neurological abnormalities. It had lost its fear of humans, was ataxic with a high-stepping gait, circling, and exhibited torticollis and a fixed vacant stare. Additional clinical signs included ptyalism with frothing from the mouth and dyspnea, with a gurgling respiration. The animal was euthanized and at necropsy, gross examination revealed multifocal masses that had effaced the normal architecture of the tracheobronchial lymph nodes and lung parenchyma. Lesions were absent from the liver, kidney and alimentary tract. A Cryptococcus species was isolated from a tracheobronchial lymph node aspirate and genotyped as C. gattii VGIIb by MLST typing [13].
The second case was an adult free-ranging, male Roosevelt elk (Cervus elaphus roosevelti), approximately two years-of-age from USA [92]. The animal had a two-day history of circling to the left. In the same area, two or three other elk with similar signs had been noticed over the previous two years; however, none of these animals had been submitted for postmortem examination. Since the elk exhibited several neurological signs and had the potential for coming into contact with domestically raised Rocky Mountain elk, it was culled by the local wildlife authorities. At necropsy, gross lesions were found only in the brain. Based on the histopathological and microbiological findings, a definitive diagnosis of meningoencephalitis and pneumonia caused by C. neoformans species complex was made.
The white-tailed deer is a new host species for C. gattii in North America. Because this species is non-migratory, exhibiting only minor seasonal movements [93], this infection was considered autochthonous, indicating endemicity of the C. gattii VGIIb-like variant in Nova Scotia. This yet again highlights the value of non-migratory animals as sentinels for emerging infectious diseases [51,94].
Similarly, autochthonous cryptococcosis was described in small ruminants reared semi-extensively [95] or extensively in the Mediterranean area [96,97]. In goats, cryptococcosis developed as pulmonary and neurological disease mostly. Neurological signs, including ataxia, nystagmus, blindness, opisthotonos and progressive paralysis, have been described starting from few days prior to euthanasia or death and necropsy [96,98]. In the Mediterranean basin, human and animal cryptococcosis is mostly caused by C. neoformans species complex strains, yet C. gattii VGI was the cause of infection in the five caprine cryptococcosis outbreaks occurring over the period 1990–94 in Spain and over the 1994–2001 in Sardinia Island (Italy) [96,97]. These cases in sheep, goats, camelids and horses will be discussed in much greater detail in a subsequent review (Danesi and colleagues, in preparation).
Phylogenetic analysis demonstrated that the Italian C. gattii VGI isolates clustered more closely with environmental isolates from Alicante in the southeast Mediterranean coast of Spain than with those from other parts of Italy [96]. The authors’ speculation is that the typical goat breed, the Murciana, raised in the Murcia region (Alicante) but extensively exported across the Mediterranean area, including Sardinia, probably resulted in asymptomatic carrier goats (colonized by VGI) being responsible for the introduction of this molecular type of C. gattii to Sardinia. Such translocation events have been well demonstrated in koalas exported within Australia, or from Australia to Japan, and in people who have visited Vancouver Island from Europe [77,78,99].
More recently, the presence of C. neoformans and C. gattii species complexes in the Mediterranean environment in association with various tree species was supported by botanical investigations [23,100]. Various authors have suggested that trees might represent a significant environmental niche and a stable reservoir for both species. In contrast, bird guano might represent a secondary transient niche, especially for the C. neoformans species complex [23]. Other than eucalypt trees that have been present in the Mediterranean basin since the end of the 18th century [101], C. gattii VGI is most likely to be isolated additionally from Carob (Ceratonia siliqua) and Olive trees in a European setting [23,100]. The evidence that Carob trees are widely cultivated in all southern Mediterranean areas, Portugal, Italy and Spain, representing the most important producers worldwide, drives the hypothesis that they represent a crucial environment niche for animal exposure in these countries.

7. Discussion

This review has presented a great deal of information about cryptococcosis in a range of different species—with emphasis on disease features in wildlife, both free-living and in captivity, as opposed to the companion animals which tend to get the most attention in the veterinary literature (viz cat, dog, ferret, horse and birds) [29,102,103].
What then are the key messages for a mycologist interested in a holistic understanding of fungal disease pathogenesis?
For the authors, the most remarkable insights come from the appreciation of the importance of the interplay between the (i) mammalian host, (ii) the environment in which it lives and (iii) the nature of the cryptococcal species with the potential to colonize, invade and potentially cause subclinical or clinical disease.
In terms of the host, it comes down to size considerations, comparative anatomy (especially of the respiratory tract), body temperature and behavior. Large and relatively athletic animals such as goats, cheetahs and horses are more likely to have tracheal and lung involvement, as deep breaths during exercise might bypass filtering of the sinonasal cavity, permitting basidiospores to penetrate deep into the bronchial tree. In cats and ferrets, by way of contrast, filtration and turbulence make for better capture of spores by the ciliated respiratory mucosa of the nasal turbinates. However, most vulnerable of all species are the Cetacea that have lost the normal mammalian nasal filtering mechanism and instead breathe through a blowhole, taking large tidal volumes into the respiratory bronchioles with the deep inspirations which immediately precede a dive. It is for this reason that porpoises and dolphins are so susceptible to the acquisition of cryptococcosis in places with a high environmental presence of infective propagules, such as off the coast of Vancouver Island, resulting from heavy run-off of spores into the ocean.
Body temperature is also a critical consideration. Cryptococcus species complexes fungi, as a generalization, prefer cooler temperatures, although they can survive at core mammalian body temperature. Thus, avian species that maintain core body temperatures of approximately 40 °C often have cryptococcal disease restricted to the upper respiratory tract, which is cooler, while birds such as the kiwi are much more vulnerable to disseminated disease as they have a much lower core body temperature. Behavior also has large impacts, which explains why arboreal koalas have the highest disease presence of all Australian mammals.
Clearly, an animal’s environment determines the extent to which there is exposure to the environmental niche of the fungus, and hence the range of inoculums to which an individual might be exposed. Therefore, an arboreal mammal such as a koala is more likely to be exposed to C. gattii VGI whose best-established niche is in detritus within well-developed tree hollows. As a result, cryptococcosis is more common in koalas than wombats, a closely related species which forages on the ground and lives in burrows. Instead, the wombat is exposed to alternate fungal pathogens such as Emmonsia [104]. What about the fascinating case clusters that have occurred affecting multiple animals simultaneously, such as flocks of sheep in WA [64,105] and the goats [96] in several parts of Spain? Presumably, there are environmental factors, such as the large stands of Australian eucalyptus trees in Spain, which favor an unusually heavy inoculum of infective propagules at certain times of the year. The environment in Vancouver Island likewise might be related to special features of that bioclimatic zone that have developed as a result of climate change and global warming.
Finally, cryptococcal biotype can be a critical consideration. C. gattii VGII, where it occurs, seems to be especially virulent. This manifests as a higher prevalence of disease in all species (including man and companion animals), and the appearance of overt cryptococcosis in unusual hosts, such as ferrets, horses and marine mammals. This is a feature of VGII equally in Vancouver Island, and in the southwest of Western Australia.
The carriage of cryptococcal fungal elements is believed to be possible through long distances with posterior seeding in new geographic areas [106]. The travel of this pathogen via translocation of wildlife has also been described [107]. The fact that the disease can emerge long after the actual seeding and that a potential increase in the virulence is proposed is a strong argument for monitoring spontaneous cryptococcosis in the wildlife [106,108]. The surveillance of animal cases may flag areas of a higher risk for environmental transmission to humans and other animals as well as the emergence of new areas [109].
Therefore, the breadth of this review makes us focus on which factors are at play in a given clinical scenario—whether it is a flock of sheep with cryptococcosis in Western Australia, a cluster of dolphins off Vancouver Island or a collection of koalas in a wildlife park in Sydney or Perth. This is the reason why studying the occurrence of cryptococcal disease holistically by considering disease in all susceptible hosts is such a powerful investigative tool, as is common for some animal species to act as a disease sentinel in a given geographical location—due to either host factors, environmental factors or the biotope associated with that region. This interplay is illustrated graphically in Figure 5 [110].

Author Contributions

Conceptualization, R.M.; writing—original draft preparation, P.D., C.F., L.H.M.d.M., L.J.S.; writing—review and editing, R.M. and M.K.; supervision, R.M.; funding acquisition, R.M. and M.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

Authors thank Paul Canfield for use of the host–pathogen–environment interaction diagram and many discussions about the pathogenesis of disease.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Iatta, R.; Immediato, D.; Puttilli, M.R.; Danesi, P.; Passantino, G.; Parisi, A.; Mallia, E.; Otranto, D.; Cafarchia, C. Cryptococcus neoformans in the respiratory tract of squirrels, Callosciurus finlaysonii (Rodentia, Sciuridae). Med. Mycol. 2015, 53, 666–673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Cafarchia, C.; Romito, D.; Iatta, R.; Camarda, A.; Montagna, M.T.; Otranto, D. Role of birds of prey as carriers and spreaders of Cryptococcus neoformans and other zoonotic yeasts. Med. Mycol. 2006, 44, 485–492. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Kwon-Chung, K.J.; Bennett, J.E.; Wickes, B.L.; Meyer, W.; Cuomo, C.A.; Wollenburg, K.R.; Bicanic, T.A.; Castañeda, E.; Chang, Y.C.; Chen, J.; et al. The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis. mSphere 2017, 2, 1–7. [Google Scholar] [CrossRef] [Green Version]
  4. Kwon-Chung, K.J.; Fraser, J.A.; Doering, T.Á.L.; Wang, Z.A.; Janbon, G.; Idnurm, A.; Bahn, Y.S. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb. Perspect. Med. 2015, 4, a019760. [Google Scholar] [CrossRef] [PubMed]
  5. Wilson, D.E.; Bennett, J.E.; Bailey, J.W. Serologic Grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol Med. 1968, 127, 820–823. [Google Scholar] [CrossRef]
  6. Kwon-Chung, K.J. A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 1975, 67, 1197–1200. [Google Scholar] [CrossRef]
  7. Kwon-Chung, K.J. A New Species of Filobasidiella, the Sexual State of Cryptococcus neoformans B and C Serotypes. Mycologia 1976, 68, 942. [Google Scholar] [CrossRef]
  8. D’Souza, C.; Kronstad, J.; Taylor, G.; Warren, R.; Yuen, M.; Hu, G.; Jung, W.; Sham, A.; Kidd, S.; Tangen, K.; et al. Genome Variation in Cryptococcus gattii, an Emerging Pathogen of. MBio 2011, 2, 1–11. [Google Scholar] [CrossRef] [Green Version]
  9. Kwon-Chung, K.J.; Boekhout, T.; Fell, J.W.; Diaz, M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 2002, 51, 804–806. [Google Scholar] [CrossRef]
  10. Kwon-Chung, K.J.; Varma, A. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res. 2006, 6, 574–587. [Google Scholar] [CrossRef] [Green Version]
  11. Meyer, W.; Castañeda, A.; Jackson, S.; Huynh, M.; Castañeda, E.; Arechavala, A.; Davel, G.; Rodero, L.; Perrotta, D.; Lazera, M.; et al. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg. Infect. Dis. 2003, 9, 189–195. [Google Scholar] [CrossRef]
  12. Boekhout, T.; Theelen, B.; Diaz, M.; Fell, J.W.; Hop, W.C.J.; Abeln, E.C.A.; Dromer, F.; Meyer, W. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 2001, 147, 891–907. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Meyer, W.; Aanensen, D.M.; Boekhout, T.; Cogliati, M.; Diaz, M.R.; Esposto, M.C.; Fisher, M.; Gilgado, F.; Hagen, F.; Kaocharoen, S.; et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med. Mycol. 2009, 47, 561–570. [Google Scholar] [CrossRef] [Green Version]
  14. Meyer, W. Cryptococcus gattii in the age of whole-genome sequencing. mBio 2015, 6, 6–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Cuomo, C.A.; Rhodes, J.; Desjardins, C.A. Advances in cryptococcus genomics: Insights into the evolution of pathogenesis. Mem. Inst. Oswaldo Cruz 2018, 113, 1–7. [Google Scholar] [CrossRef] [Green Version]
  16. Bovers, M.; Hagen, F.; Kuramae, E.E.; Boekhout, T. Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing. Fungal Genet. Biol. 2008, 45, 400–421. [Google Scholar] [CrossRef] [PubMed]
  17. Ngamskulrungroj, P.; Gilgado, F.; Faganello, J.; Litvintseva, A.P.; Leal, A.L.; Tsui, K.M.; Mitchell, T.G.; Vainstein, M.H.; Meyer, W. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS ONE 2009, 4, e5862. [Google Scholar] [CrossRef]
  18. Hagen, F.; Khayhan, K.; Theelen, B.; Kolecka, A.; Polacheck, I.; Sionov, E.; Falk, R.; Parnmen, S.; Lumbsch, H.T.; Boekhout, T. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet. Biol. 2015, 78, 16–48. [Google Scholar] [CrossRef] [Green Version]
  19. Mitchell, T.G.; Castañeda, E.; Nielsen, K.; Wanke, B.; Lazéra, M.S. Environmental Niches for Cryptococcus neoformans and Cryptococcus gattii. In Cryptococcus: From Human Pathogen to Model Yeast; Heitman, J., Kozel, T., Kwon-Chung, K., Perfect, J., Casadevall, A., Eds.; American Society for Microbiology: Washington, DC, USA, 2011; pp. 237–259. ISBN 9781555816858. [Google Scholar]
  20. Staib, F. Cryptococcus neoformans in canaries. Zentralbl. Bakteriol. 1962, 185, 129–134. [Google Scholar]
  21. Casadevall, A.; Freij, J.B.; Hann-Soden, C.; Taylor, J. Continental Drift and Speciation of the Cryptococcus neoformans and Cryptococcus gattii Species Complexes. mSphere 2017, 2, 1–6. [Google Scholar] [CrossRef] [Green Version]
  22. Engelthaler, D.M.; Meyer, W. Furthering the Continental Drift Speciation Hypothesis in the Pathogenic Cryptococcus Species Complexes. mSphere 2017, 2, 1–3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Cogliati, M.; D’Amicis, R.; Zani, A.; Montagna, M.T.; Caggiano, G.; De Giglio, O.; Balbino, S.; De Donno, A.; Serio, F.; Susever, S.; et al. Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin. FEMS Yeast Res. 2016, 16, fow045. [Google Scholar] [CrossRef] [Green Version]
  24. Mörner, T.; Avenäs, A.; Mattsson, R. Adiaspiromycosis in a European beaver from Sweden. J. Wildl. Dis. 1999, 35, 367–370. [Google Scholar] [CrossRef] [PubMed]
  25. Cafarchia, C.; Camarda, A.; Romito, D.; Campolo, M.; Quaglia, N.C.; Tullio, D.; Otranto, D. Occurrence of yeasts in cloacae of migratory birds. Mycopathologia 2006, 161, 229–234. [Google Scholar] [CrossRef] [PubMed]
  26. Springer, D.J.; Mohan, R.; Heitman, J. Plants promote mating and dispersal of the human pathogenic fungus Cryptococcus. PLoS ONE 2017, 12, 1–21. [Google Scholar] [CrossRef] [PubMed]
  27. Coelho, C.; Farrer, R.A. Pathogen and Host Genetics Underpinning Cryptococcal Disease, 1st ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2020; Volume 105, ISBN 9780128216859. [Google Scholar]
  28. Chen, S.C.A.; Meyer, W.; Sorrell, T.C. Cryptococcus gattii infections. Clin. Microbiol. Rev. 2014, 27, 980–1024. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Malik, R.; Krockenberger, M.B.; O’Brien, C.R.; Carter, D.A.; Meyer, W.; Canfield, P.J. Veterinary Insights into Cryptococcosis Caused by Cryptococcus neoformans and Cryptococcus gattii. In Cryptococcus: From Human Pathogen to Model Yeast; Heitman, J., Kozel, T., Kwon-Chung, K., Perfect, J., Casadevall, A., Eds.; American Society for Microbiology: Washington, DC, USA, 2011; pp. 489–504. ISBN 9781555816858. [Google Scholar]
  30. Trivedi, S.R.; Malik, R.; Meyer, W.; Sykes, J.E. Feline cryptococcosis. Impact of current research on clinical management. J. Feline Med. Surg. 2011, 13, 163–172. [Google Scholar] [CrossRef]
  31. Ma, H.; May, R.C. Virulence in Cryptococcus species. Adv. Appl. Microbiol. 2009, 67, 131–190. [Google Scholar] [CrossRef]
  32. Casadevall, A.; Steenbergen, J.N.; Nosanchuk, J.D. ‘Ready made’ virulence and ‘dual use’ virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm. Curr. Opin. Microbiol. 2003, 6, 332–337. [Google Scholar] [CrossRef]
  33. Casadevall, A.; Fu, M.S.; Guimaraes, A.J.; Albuquerque, P. The ‘Amoeboid Predator-Fungal Animal Virulence’ Hypothesis. J. Fungi 2019, 5, 10. [Google Scholar] [CrossRef] [Green Version]
  34. Castellani, A. Phagocytic and destructive action of Hartmanella castellanii (Amoeba castellanii) on pathogenic encapsulated yeast-like fungi Torulopsis neoformans (Cryptococcus neoformans). Ann. Inst. Pasteur. 1955, 89, 1–7. [Google Scholar]
  35. Chrisman, C.J.; Albuquerque, P.; Guimaraes, A.J.; Nieves, E.; Casadevall, A. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog. 2011, 7, e1002047. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Dromer, F.; Casadevall, A.; Perfect, J.; Sorrell, T. Cryptococcus neoformans: Latency and Disease. In Cryptococcus: From Human Pathogen to Model Yeast; Heitman, J., Kozel, T., Kwon-Chung, K., Perfect, J., Casadevall, A., Eds.; American Society for Microbiology: Washington, DC, USA, 2011; pp. 431–439. ISBN 9781555816858. [Google Scholar]
  37. Perfect, J.R.; Casadevall, A. Cryptococcosis. Infect. Dis Clin. N. Am. 2002, 16, 837–874. [Google Scholar] [CrossRef]
  38. Boyce, K.J.; Andrianopoulos, A. Fungal dimorphism: The switch from hyphae to yeast is a specialized morphogenetic adaptation allowing colonization of a host. FEMS Microbiol. Rev. 2015, 39, 797–811. [Google Scholar] [CrossRef] [Green Version]
  39. Heitman, J.; Sun, S.; James, T.Y. Evolution of fungal sexual reproduction. Mycologia 2013, 105, 1–27. [Google Scholar] [CrossRef]
  40. Coelho, C.; Bocca, A.L.; Casadevall, A. The intracellular life of Cryptococcus neoformans. Annu. Rev. Pathol. 2014, 9, 219–238. [Google Scholar] [CrossRef] [Green Version]
  41. Velagapudi, R.; Hsueh, Y.P.; Geunes-Boyer, S.; Wright, J.R.; Heitman, J. Spores as infectious propagules of Cryptococcus neoformans. Infect. Immun. 2009, 77, 4345–4355. [Google Scholar] [CrossRef] [Green Version]
  42. Zhao, Y.; Lin, J.; Fan, Y.; Lin, X. Life cycle of Cryptococcus neoformans. Annu. Rev. Microbiol. 2019, 73, 17–42. [Google Scholar] [CrossRef]
  43. Ellis, D.H.; Pfeiffer, T.J. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 1990, 336, 923–925. [Google Scholar] [CrossRef]
  44. Halliday, C.L.; Bui, T.; Krockenberger, M.; Malik, R.; Ellis, D.H.; Carter, D.A. Presence of α and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J. Clin. Microbiol. 1999, 37, 2920–2926. [Google Scholar] [CrossRef] [Green Version]
  45. Littman, M.L.; Borok, R. Relation of the pigeon to cryptococcosis: Natural carrier state, heat resistance and survival of Cryptococcus neoformans. Mycopathol. Mycol. Appl. 1968, 35, 329–345. [Google Scholar] [CrossRef] [PubMed]
  46. Konicek, C.; Vodrážka, P.; Barták, P.; Knotek, Z.; Hess, C.; Račka, K.; Hess, M.; Troxler, S. Detection of zoonotic pathogens in wild birds in the cross-border region Austria–Czech Republic. J. Wildl. Dis. 2016, 52, 850–861. [Google Scholar] [CrossRef] [Green Version]
  47. Nielsen, K.; De Obaldia, A.L.; Heitman, J. Cryptococcus neoformans mates on pigeon guano: Implications for the realized ecological niche and globalization. Eukaryot Cell 2007, 6, 949–959. [Google Scholar] [CrossRef] [Green Version]
  48. Krockenberger, M.; Stalder, K.; Malik, R.; Canfield, P. Cryptococcosis in Australian Wildlife. Microbiol. Aust. 2005, 26, 69–73. [Google Scholar] [CrossRef]
  49. Byrnes, E.J., 3rd; Bildfell, R.J.; Dearing, P.L.; Valentine, B.A.; Heitman, J. Cryptococcus gattii with bimorphic colony types in a dog in western Oregon: Additional evidence for expansion of the Vancouver Island outbreak. J. Vet. Diagn. Invest. 2009, 21, 133–136. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Duncan, C. The Emergence of Cryptococcus gattii in British Columbia: Veterinary Aspects. Master’s Thesis, University of Saskatchewan, Saskatoon, SK, Canada, June 2005. [Google Scholar]
  51. Duncan, C.; Schwantje, H.; Stephen, C.; Campbell, J.; Bartlett, K. Cryptococcus gattii in wildlife of Vancouver Island, British Columbia, Canada. J. Wildl. Dis. 2006, 42, 175–178. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Stephen, C.; Lester, S.; Black, W.; Fyfe, M.; Raverty, S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can. Vet. J. 2002, 43, 792–794. [Google Scholar] [PubMed]
  53. Farrer, R.A.; Chang, M.; Davis, M.J.; van Dorp, L.; Yang, D.H.; Shea, T.; Sewell, T.R.; Meyer, W.; Balloux, F.; Edwards, H.M.; et al. A new lineage of Cryptococcus gattii (VGV) discovered in the central zambezian miombo woodlands. mBio 2019, 10, e02306-19. [Google Scholar] [CrossRef] [Green Version]
  54. Taylor, J.W.; Barker, B.M. The endozoan, small-mammal reservoir hypothesis and the life cycle of Coccidioides species. Med. Mycol. 2019, 57, S16–S20. [Google Scholar] [CrossRef]
  55. Scott, L. Hyrax (Procaviidae) and dassie rat (Petromuridae) middens in palaeoenvironmental studies in Africa. In Packrat middens: The Last 40,000 Years of Biotic Change; Jilio, L., Betancourt, T.R., van Devender, T.R., Martin, P.S., Eds.; University of Arizona Press: Tucson, AZ, USA, 1990; pp. 408–427. [Google Scholar]
  56. Chase, B.M.; Scott, L.; Meadows, M.E.; Gil-Romera, G.; Boom, A.; Carr, A.S.; Reimer, P.J.; Truc, L.; Valsecchi, V.; Quick, L.J. Rock hyrax middens: A palaeoenvironmental archive for southern African drylands. Quat. Sci. Rev. 2012, 56, 107–125. [Google Scholar] [CrossRef]
  57. Illnait-Zaragozí, M.T.; Hagen, F.; Fernández-Andreu, C.M.; Martínez-Machín, G.F.; Polo-Leal, J.L.; Boekhout, T.; Klaassen, C.H.; Meis, J.F. Reactivation of a Cryptococcus gattii infection in a cheetah (Acinonyx jubatus) held in the National Zoo, Havana, Cuba. Mycoses 2011, 54, 889–892. [Google Scholar] [CrossRef] [PubMed]
  58. Millward, I.R.; Williams, M.C. Cryptococcus neoformans granuloma in the lung and spinal cord of a free-ranging cheetah (Acinonyx jubatus). A clinical report and literature review. J. S. Afr. Vet. Assoc. 2005, 76, 228–232. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Bolton, L.A.; Lobetti, R.G.; Evezard, D.N.; Picard, J.A.; Nesbit, J.W.; Van Heerden, J.; Burroughs, R.E.J. Cryptococcosis in captive cheetah (Acinonyx jubatus): Two cases. J. S. Afr. Vet. Assoc. 1999, 70, 35–39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Berry, W.L.; Jardine, J.E.; Espie, I.W. Pulmonary cryptococcoma and cryptococcal meningoencephalomyelitis in a king cheetah (Acinonyx jubatus). J. Zoo Wildl. Med. 1997, 28, 485–490. [Google Scholar] [PubMed]
  61. Polo Leal, J.L.; Fernández Andreu, C.M.; Martínez Machín, G.; Illnait Zaragozi, M.T.; Perurena Lancha, M.R. Cyptococcus gattii isolated from a cheetah (Acinonyx jubatus) in the National Zoo of Cuba. Rev. Cubana Med. Trop. 2010, 62, 257–260. [Google Scholar]
  62. Beehler, B.A. Oral therapy for nasal cryptococcosis in a cheetah. J. Am. Vet. Med. Assoc. 1982, 181, 1400–1401. [Google Scholar] [PubMed]
  63. Bernstein, J.J. Cryptococcus osteomyelitis in a cheetah. Feline Pract. 1979, 9, 23–25. [Google Scholar]
  64. Sorrell, T.C.; Brownlee, A.G.; Ruma, P.; Malik, R.; Pfeiffer, T.J.; Ellis, D.H. Natural environmental sources of Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 1996, 34, 1261–1263. [Google Scholar] [CrossRef] [Green Version]
  65. Illnait-Zaragozí, M.T.; Martínez-Machín, G.F.; Fernández-Andreu, C.M.; Boekhout, T.; Meis, J.F.; Klaassen, C.H. Microsatellite typing of clinical and environmental Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages. PLoS ONE 2010, 5, e9124. [Google Scholar] [CrossRef]
  66. Malik, R. Genetic diseases of cats. J. Feline Med. Surg. 2001, 3, 109–113. [Google Scholar] [CrossRef]
  67. Miller-Edge, M.A.; Worley, M.B. In vitro responses of cheetah mononuclear cells to feline herpesvirus-1 and Cryptococcus neoformans. Vet. Immunol. Immunopathol. 1992, 30, 261–274. [Google Scholar] [CrossRef]
  68. Kuiken, T.; Höfle, U.; Bennett, P.M.; Allchin, C.R.; Kirkwood, J.K.; Baker, J.R.; Appleby, E.C.; Lockyer, C.H.; Walton, M.J.; Sheldrick, M.C. Adrenocortical hyperplasia, disease and chlorinated hydrocarbons in the harbour porpoise (Phocoena phocoena). Mar. Pollut. Bull. 1993, 26, 440–446. [Google Scholar] [CrossRef]
  69. McColl, K.A. Pathology in captive platypus (Ornithorhynchus anatinus) in Victoria, Australia. J. Wildl. Dis. 1983, 19, 118–122. [Google Scholar] [CrossRef] [PubMed]
  70. Munson, L. Diseases of captive cheetahs (Acinonyx jubatus): Results of the cheetah research council pathology survey, 1989–1992. Zoo Biol. 1993, 12, 105–124. [Google Scholar] [CrossRef]
  71. Rideout, B.A.; Gause, G.E.; Benirschke, K.; Lasley, B.L. Stress-induced adrenal changes and their relation to reproductive failure in captive nine-banded armadillos (Dasypus novemcinctus). Zoo Biol. 1985, 4, 129–137. [Google Scholar] [CrossRef]
  72. Schmertmann, L.J.; Stalder, K.; Hudson, D.; Martin, P.; Makara, M.; Meyer, W.; Malik, R.; Krockenberger, M.B. Cryptococcosis in the koala (Phascolarctos cinereus): Pathogenesis and treatment in the context of two atypical cases. Med. Mycol. 2018, 56, 926–936. [Google Scholar] [CrossRef]
  73. Krockenberger, M.B.; Canfield, P.J.; Malik, R. Cryptococcus neoformans var. gattii in the koala (Phascolarctos cinereus): A review of 43 cases of cryptococcosis. Med. Mycol. 2003, 41, 225–234. [Google Scholar] [CrossRef]
  74. Wynne, J.; Klause, S.; Stadler, C.K.; Pye, G.W.; Meyer, W.; Sykes, J.E. Preshipment testing success: Resolution of a nasal sinus granuloma in a captive koala (Phascolarctos cinereus) caused by Cryptococcus gattii. J. Zoo Wildl. Med. 2012, 43, 939–942. [Google Scholar] [CrossRef]
  75. Martínez-Nevado, E.; Alonso-Alegre, E.G.; Martínez, M.Á.; Rodríguez-Álvaro, A.; de Merlo, E.M.; García, J.G.; Real, I.G. Atypical presentation of Cryptococcus neoformans in a koala (Phascolarctos cinereus): A magnetic resonance imaging and computed tomography study. J. Zoo Wildl. Med. 2017, 48, 250–254. [Google Scholar] [CrossRef]
  76. Waugh, C.A.; Hanger, J.; Loader, J.; King, A.; Hobbs, M.; Johnson, R.; Timms, P. Infection with koala retrovirus subgroup B (KoRV-B), but not KoRV-A, is associated with chlamydial disease in free-ranging koalas (Phascolarctos cinereus). Sci. Rep. 2017, 7, 1–11. [Google Scholar] [CrossRef] [Green Version]
  77. Krockenberger, M.B. (The University of Sydney, Sydney, Australia). Personal communication, 2020.
  78. Schmertmann, L.J.; Irinyi, L.; Malik, R.; Powell, J.R.; Meyer, W.; Krockenberger, M.B. The mycobiome of Australian tree hollows in relation to the Cryptococcus gattii and C. neoformans species complexes. Ecol. Evol. 2019, 9, 9684–9700. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Rotstein, D.S.; West, K.; Levine, G.; Lockhart, S.R.; Raverty, S.; Morshed, M.G.; Rowles, T. Cryptococcus gattii VGI in a spinner dolphin (Stenella longirostris) from Hawaii. J. Zoo Wildl. Med. 2010, 41, 181–183. [Google Scholar] [CrossRef] [PubMed]
  80. Gales, N.; Wallace, G.; Dickson, J. Pulmonary cryptococcosis in a striped dolphin (Stenella coeruleoalba). J. Wildl. Dis. 1985, 21, 443–446. [Google Scholar] [CrossRef]
  81. Mouton, M.; Reeb, D.; Botha, A.; Best, P. Yeast infection in a beached southern right whale (Eubalaena australis) neonate. J. Wildl. Dis. 2009, 45, 692–699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Mcleland, S.; Duncan, C.; Spraker, T.; Wheeler, E.; Lockhart, S.R.; Gulland, F. Cryptococcus albidus infection in a California sea lion (Zalophus californianus). J. Wildl. Dis. 2012, 48, 1030–1034. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Migaki, G.; Gunnels, R.D.; Casey, H.W. Pulmonary cryptococcosis in an Atlantic bottlenosed dolphin (Tursiops truncatus). Lab. Anim. Sci. 1978, 28, 603–606. [Google Scholar]
  84. Field, C.L.; Tuttle, A.D.; Sidor, I.F.; Nyaoke, A.; Deering, K.M.; Gilbert-Marcheterre, K.; Risatti, G.; Spoon, T.; Meegan, J.; Romano, T.A.; et al. Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA. J. Zoo Wildl. Med. 2012, 43, 144–152. [Google Scholar] [CrossRef] [PubMed]
  85. Lee, M.K.; Man, S.; Balbimie, A.; Mithani, S.; Wong, Q.; Zabek, E.; Raverty, S.; Hoang, L.M. Molecular Characteristics of Cryptococcus isolates from Marine Mammals stranded along the Pacific Northwest Coast. In Proceedings of the Infectious Diseases Society of America (IDSA) 48th Annual Meeting, Vancouver, BC, Canada, 21–24 October 2010. [Google Scholar]
  86. Miller, W.G.; Padhye, A.A.; Van Bonn, W.; Jensen, E.; Brandt, M.E.; Ridgway, S.H. Cryptococcosis in a bottlenose dolphin (Tursiops truncatus) caused by Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 2002, 40, 721–724. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Rosenberg, J.F.; Haulena, M.; Hoang, L.M.N.; Morshed, M.; Zabek, E.; Raverty, S.A. Cryptococcus gattii type VGIIa infection in harbor seals (Phoca vitulina) in British Columbia, Canada. J. Wildl. Dis. 2016, 52, 677–681. [Google Scholar] [CrossRef]
  88. Norman, S.A.; Raverty, S.; Zabek, E.; Etheridge, S.; Ford, J.K.; Hoang, L.M.; Morshed, M. Maternal–Fetal Transmission of Cryptococcus gattii in Harbor Porpoise. Emerg. Infect. Dis. 2011, 17, 304–305. [Google Scholar] [CrossRef]
  89. Huckabone, S.E.; Gulland, F.M.D.; Johnson, S.M.; Colegrove, K.M.; Dodd, E.M.; Pappagianis, D.; Dunkin, R.C.; Casper, D.; Carlson, E.L.; Sykes, J.E.; et al. Coccidioidomycosis and other systemic mycoses of marine mammals stranding along the central California, USA coast: 1998–2012. J. Wildl. Dis 2015, 51, 295–308. [Google Scholar] [CrossRef]
  90. Reidarson, T.H.; McBain, J.F.; Dalton, J.M.; Rinaldi, M.G. Marine Mammal Mycoses. In CRC Handbook of Marine Mammal Medicine; Dierauf, L.A., Gulland, F., Eds.; CRC Press: New York, NY, USA, 2001; pp. 337–356. ISBN 9781498796873. [Google Scholar]
  91. Overy, D.P.; McBurney, S.; Muckle, A.; Lund, L.; Lewis, P.J.; Strang, R. Cryptococcus gattii VGIIb-like variant in white-tailed deer, Nova Scotia, Canada. Emerg. Infect. Dis. 2016, 22, 1131–1133. [Google Scholar] [CrossRef] [Green Version]
  92. Hamir, A.N.; Miller, J.M.; Sonn, R.J. Meningoencephalitis and pneumonia associated with Cryptococcus neoformans infection in a free-ranging elk in the USA. Vet. Rec. 2002, 151, 332–333. [Google Scholar] [CrossRef]
  93. Olsson, M.P.O.; Cox, J.; Larkin, J.L.; Maehr, D.S.; Widen, P.; Wichrowski, M.W. Movement and Activity Patterns of Translocated Elk (Cervus elaphus Nelsoni) on an Active Coal Mine in Kentucky. Wildl. Biol. Pract. 2007, 3, 1–8. [Google Scholar] [CrossRef]
  94. Morera, N.; Hagen, F.; Juan-Sallés, C.; Artigas, C.; Patricio, R.; Serra, J.I.; Colom, M.F. Ferrets as sentinels of the presence of pathogenic Cryptococcus species in the Mediterranean environment. Mycopathologia. 2014, 178, 145–151. [Google Scholar] [CrossRef]
  95. Headley, S.A.; Pimentel, L.A.; Michelazzo, M.Z.; Toma, H.S.; Pretto-Giordano, L.G.; Marcasso, R.A.; Amude, A.M.; Oliveira, T.E.; Santos, M.D.; Krockenberger, M. Pathologic, histochemical, and immunohistochemical findings in pulmonary and encephalitic cryptococcosis in a goat. J. Vet. Diagn. Invest. 2019, 31, 69–73. [Google Scholar] [CrossRef]
  96. Baró, T.; Torres-Rodríguez, J.M.; De Mendoza, M.H.; Morera, Y.; Alía, C. First identification of autochthonous Cryptococcus neoformans var. gattii isolated from goats with predominantly severe pulmonary disease in Spain. J. Clin. Microbiol. 1998, 36, 458–461. [Google Scholar] [CrossRef] [Green Version]
  97. Maestrale, C.; Masia, M.; Pintus, D.; Lollai, S.; Kozel, T.R.; Gates-Hollingsworth, M.A.; Cancedda, M.G.; Cabras, P.; Pirino, S.; D’Ascenzo, V.; et al. Genetic and pathological characteristics of Cryptococcus gattii and Cryptococcus neoformans var. neoformans from meningoencephalitis in autochthonous goats and mouflons, Sardinia, Italy. Vet. Microbiol. 2015, 177, 409–413. [Google Scholar] [CrossRef]
  98. Rosa, F.B.; Rubin, M.; Olinda, R.G.; Leal, P.; Lima, S.; Pupin, R.C.; Gomes, D.; Lemos, R.; Martins, T.B.; Rodrigues-Hoffmann, A.; et al. Granulomatous leptomeningitis in a goat associated with infection by Cryptococcus neoformans. Braz. J. Vet. Pathol. 2016, 9, 98–102. [Google Scholar]
  99. Makimura, K.; Karasawa, M.; Hosoi, H.; Kobayashi, T.; Kamijo, N.; Kobayashi, K.; Hiramatsu, H.; Akikawa, T.; Yabe, T.; Yamaguchi, A.; et al. A Queensland koala kept in a Japanese zoological park was carrier of an imported fungal pathogen, Filobasidiella neoformans var. bacillispora (Cryptococcus neoformans var. gattii). Jpn. J. Infect. Dis. 2002, 55, 31–32. [Google Scholar]
  100. Colom, M.F.; Hagen, F.; Gonzalez, A.; Mellado, A.; Morera, N.; Linares, C.; García, D.F.; Peñataro, J.S.; Boekhout, T.; Sánchez, M. Ceratonia siliqua (carob) trees as natural habitat and source of infection by Cryptococcus gattii in the Mediterranean environment. Med. Mycol. 2012, 50, 67–73. [Google Scholar] [CrossRef] [Green Version]
  101. Silva-Pando, F.J.; Pino-Pérez, R. Introduction of Eucalyptus into Europe. Aust For. 2016, 79, 283–291. [Google Scholar] [CrossRef]
  102. Malik, R.; Krockenberger, M.B.; Cross, G.; Doneley, R.; Madill, D.N.; Black, D.; Mcwhirter, P.; Rozenwax, A.; Rose, K.; Alley, M.; et al. Avian cryptococcosis. Med. Mycol. 2003, 41, 115–124. [Google Scholar] [CrossRef]
  103. Secombe, C.J.; Lester, G.D.; Krockenberger, M.B. Equine Pulmonary Cryptococcosis: A Comparative Literature Review and Evaluation of Fluconazole Monotherapy. Mycopathologia 2017, 182, 413–423. [Google Scholar] [CrossRef]
  104. Danesi, P.; Falcaro, C.; Dukik, K.; Jiang, Y.; Rizzoli, A.P.; Allavena, R.; Simpson, V.; Ravagnan, S.; Zanardello, C.; Capelli, G.; et al. Molecular Diagnosis of Emmonsia-Like Fungi Occurring in Wild Animals. Mycopathologia 2020, 185, 51–65. [Google Scholar] [CrossRef]
  105. McGill, S.; Malik, R.; Saul, N.; Beetson, S.; Secombe, C.; Robertson, I.; Irwin, P. Cryptococcosis in domestic animals in Western Australia: A retrospective study from 1995–2006. Med. Mycol. 2009, 47, 625–639. [Google Scholar] [CrossRef] [Green Version]
  106. Engelthaler, D.M.; Casadevall, A. On the emergence of Cryptococcus gattii in the pacific northwest: Ballast Tanks, Tsunamis, and black swans. mBio 2019, 10, e02193-19. [Google Scholar] [CrossRef] [Green Version]
  107. Kido, N.; Makimura, K.; Kamegaya, C.; Shindo, I.; Shibata, E.; Omiya, T.; Yamamoto, Y. Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus). Med. Mycol. 2012, 50, 291–298. [Google Scholar] [CrossRef] [Green Version]
  108. Ali, M.F.; Tansie, S.M.; Shahan, J.R.; Seipelt-Thiemann, R.L.; McClelland, E.E. Serial Passage of Cryptococcus neoformans in Galleria mellonella results in increased capsule and intracellular replication in hemocytes, but not increased resistance to hydrogen peroxide. Pathogens 2020, 9, 732. [Google Scholar] [CrossRef]
  109. Rabinowitz, P.M.; Kock, R.; Kachani, M.; Kunkel, R.; Thomas, J.; Gilbert, J.; Wallace, R.; Blackmore, C.; Wong, D.; Karesh, W.; et al. Toward proof of concept of a one health approach to disease prediction and control. Emerg. Infect. Dis. 2013, 19, e130265. [Google Scholar] [CrossRef]
  110. Canfield, P.J.; Krockenberger, M.B.; Higgins, D.P. Koalas. In Proceedings of the Wildlife Pathology Short Course, Taronga Zoo, Sydney, Australia, 21–24 August 2008. [Google Scholar]
Figure 1. Historical nomenclature of C. neoformans and C. gattii species complex. * Hagen et al., 2015 [18]; # hybrid (Modified from Kwon-Chung et al., 2017 [3]).
Figure 1. Historical nomenclature of C. neoformans and C. gattii species complex. * Hagen et al., 2015 [18]; # hybrid (Modified from Kwon-Chung et al., 2017 [3]).
Jof 07 00029 g001
Figure 2. Cryptococcosis caused by C. gattii VGI in a 12 month old female koala (AD) presenting with severe dyspnea and tachypnea and later developing seizures. (A) Lung at low magnification. There is marked consolidation of the pulmonary parenchyma. Some large airways containing exudate are evident. (B) The lungs exhibit a diffuse marked increase in cellularity due to an inflammatory infiltrate predominantly made up of macrophages. Note the budding yeast with the large negatively staining capsule. (C) In some parts of the specimen, the negatively stained capsule around the yeast is very large and there is an associated multinucleate giant cell macrophage response. (D) The thoracic lymph node exhibits a complete loss of normal architecture and is replaced almost entirely by large aggregates of encapsulated yeast cells, with some surrounding pyogranulomatous inflammatory infiltrate in places. (E) Lung at high magnification from a young male koala that presented with dyspnea, lymphadenomegaly and multifocal skin lesions associated with cryptococcosis caused by C. gattii VGI. There was significant widespread severe lung consolidation present at necropsy, in addition to multifocal lymph node involvement and multifocal skin lesions. Note the encapsulated yeast in the multinucleate giant cell macrophage.
Figure 2. Cryptococcosis caused by C. gattii VGI in a 12 month old female koala (AD) presenting with severe dyspnea and tachypnea and later developing seizures. (A) Lung at low magnification. There is marked consolidation of the pulmonary parenchyma. Some large airways containing exudate are evident. (B) The lungs exhibit a diffuse marked increase in cellularity due to an inflammatory infiltrate predominantly made up of macrophages. Note the budding yeast with the large negatively staining capsule. (C) In some parts of the specimen, the negatively stained capsule around the yeast is very large and there is an associated multinucleate giant cell macrophage response. (D) The thoracic lymph node exhibits a complete loss of normal architecture and is replaced almost entirely by large aggregates of encapsulated yeast cells, with some surrounding pyogranulomatous inflammatory infiltrate in places. (E) Lung at high magnification from a young male koala that presented with dyspnea, lymphadenomegaly and multifocal skin lesions associated with cryptococcosis caused by C. gattii VGI. There was significant widespread severe lung consolidation present at necropsy, in addition to multifocal lymph node involvement and multifocal skin lesions. Note the encapsulated yeast in the multinucleate giant cell macrophage.
Jof 07 00029 g002
Figure 3. (A) Primary pulmonary cryptococcoma (yellow star) in a lateral chest radiograph from a captive cheetah. The “glassy-eyed stare” seen with peripheral blindness is evident in (C), which shows the cheetah being given a subcutaneous infusion of amphotericin B. The patient after successful therapy is shown in (B), with its carer; note the alert demeanor and normal posture.
Figure 3. (A) Primary pulmonary cryptococcoma (yellow star) in a lateral chest radiograph from a captive cheetah. The “glassy-eyed stare” seen with peripheral blindness is evident in (C), which shows the cheetah being given a subcutaneous infusion of amphotericin B. The patient after successful therapy is shown in (B), with its carer; note the alert demeanor and normal posture.
Jof 07 00029 g003
Figure 4. Cryptococcosis in the koala. (A) Koala with sinonasal cryptococcosis undergoing a computerized tomography scan. (B) Koala with destructive cryptococcal rhinitis due to C. gattii. (C) Multifocal skin involvement over the planum nasale of a koala with C. gattii infection. (D) Lungs from a koala that died of pneumonia due to C. gattii and Bordetella bronchiseptica. (E) Koala with cryptococcal rhinosinusitis with extension to the brain. (F) Koala with cryptococcal rhinitis with ventral extension to involve the hard palate.
Figure 4. Cryptococcosis in the koala. (A) Koala with sinonasal cryptococcosis undergoing a computerized tomography scan. (B) Koala with destructive cryptococcal rhinitis due to C. gattii. (C) Multifocal skin involvement over the planum nasale of a koala with C. gattii infection. (D) Lungs from a koala that died of pneumonia due to C. gattii and Bordetella bronchiseptica. (E) Koala with cryptococcal rhinosinusitis with extension to the brain. (F) Koala with cryptococcal rhinitis with ventral extension to involve the hard palate.
Jof 07 00029 g004
Figure 5. Host–pathogen–environment interactions: the wheel that steers investigation and understanding of infectious disease development. Interactions may enhance or ameliorate disease. P, pathogen; H, host defenses; E, environment; D, disease outcome (subclinical or clinical effect on the host). For any potential pathogen, the interaction of host, pathogen and the environment determine where on the disease–outcome continuum the relationship will lie. This integration of concepts gives rise to a template of questions and generates hypotheses for use in investigating wildlife disease (adapted from ideas developed by Emeritus Professor Paul Canfield).
Figure 5. Host–pathogen–environment interactions: the wheel that steers investigation and understanding of infectious disease development. Interactions may enhance or ameliorate disease. P, pathogen; H, host defenses; E, environment; D, disease outcome (subclinical or clinical effect on the host). For any potential pathogen, the interaction of host, pathogen and the environment determine where on the disease–outcome continuum the relationship will lie. This integration of concepts gives rise to a template of questions and generates hypotheses for use in investigating wildlife disease (adapted from ideas developed by Emeritus Professor Paul Canfield).
Jof 07 00029 g005
Table 1. Cryptococcosis in wild felids.
Table 1. Cryptococcosis in wild felids.
CaseDiagnosisSpecies/VarietyOutcome
(Treatment, Necropsy)
LocationDateReferences
1Pulmonary cryptococcoma and meningomyelitis (spinal cord)Cryptococcus gattiiNecropsySouth Africa2005[58]
2Pulmonary cryptococcoma and cryptococcal meningoencephalomyelitisCryptococcus neoformansNecropsySouth Africa1997[60]
3Pulmonary cryptococcomas and extensive meningoencephalomyelitisCryptococcus neoformansNecropsySouth Africa1999[59]
4Pulmonary cryptococcomas and extensive meningoencephalomyelitisCryptococcus gattiiNecropsySouth Africa1999[59]
5Shortness of breath and nasal dischargeCryptococcus gattiiThe animal was taken to the veterinary clinic for sampling and died before any diagnosis could be madeCuba2010[61]
6Shortness of breath and nasal dischargeCryptococcus gattii AFLP4/VGI Cuba2011[57]
7Nasal cryptococcosisAbstract not available USA1982[62]
8OsteomyelitisAbstract not available [63]
Table 2. Cryptococcosis in marine mammals.
Table 2. Cryptococcosis in marine mammals.
CaseMammal SpeciesDiagnosisSpecies/VarietyOutcome
(Treatment, Necropsy)
LocationDateReferences
1Whale (Eubalaena australis) neonateSkin lesion culture positive for Candida zeylanoidesCryptococcus neoformansNecropsySouth Africa2009[81]
2Spinner dolphin (Stenella longirostris)Skin, lymph nodes and several organs (stomach, adrenal gland, kidney and spleen)Cryptococcus gattii—VGINecropsyHawaii2010[79]
3Striped Dolphin
(Stenella coeruleoalba)
Pulmonary cryptococcosis (lung and mediastinal lymph gland) and gastric mucosa. Stomach with moderate number of nematodes (Anisakis simplex)Cryptococcus spp.NecropsyWestern Australia1985[80]
4Bottlenose dolphin (Tursiops truncatus)Pulmonary Cryptococcosis Bronchopneumonia with pleuritisCryptococcus gattiiNecropsy
Itraconazole therapy
California, USA2000[86]
5Atlantic bottlenosed dolphin (Tursiops truncatus)Pulmonary cryptococcosisCryptococcus spp.NecropsyNot reported1978[83]
6Dall’s porpoise
(Phocoenoides dalli)
Pulmonary cryptococcosis with generalized lymphadenopathyCryptococcus gattiiNecropsyVancouver Island, Canada2000–2001[52]
7Dall’s porpoise
(Phocoenoides dalli)
Pulmonary cryptococcosis with generalized lymphadenopathyCryptococcus gattiiNecropsyVancouver Island, Canada2000–2001[52]
8Dall’s porpoise
(Phocoenoides dalli)
Pulmonary cryptococcosis with generalized lymphadenopathyCryptococcus neoformansNecropsyVancouver Island, Canada2000–2001[52]
9Dall’s porpoise
(Phocoenoides dalli)
Pulmonary cryptococcosis with generalized lymphadenopathyCryptococcus neoformansNecropsyVancouver Island, Canada2000–2001[52]
10Dall’s porpoise
(Phocoenoides dalli)
Pulmonary cryptococcosis with generalized lymphadenopathyCryptococcus neoformansNecropsyVancouver Island, Canada2000–2001[52]
11Harbor porpoise (Phocoena phocoena)Pulmonary cryptococcosis with generalized lymphadenopathyCryptococcus neoformansNecropsyVancouver Island, Canada2000–2001[52]
12Adult and foetus Harbor porpoise (Phocoena phocoena)Maternal–Foetal transmission of CryptococcusCryptococcus gattiiNecropsyUSA2007[88]
13PorpoiseNot reportedCryptococcus gattii—VGICulture.
Multi-Locus Sequence Typing (MLST)
Pacific Northwest Coast, Canada2010[85]
14PorpoiseNot reportedCryptococcus gattii—VGIIaCulture.
Multi-Locus Sequence Typing (MLST)
Pacific Northwest Coast, Canada2010[85]
15PorpoiseNot reportedCryptococcus gattii—VGIIaCulture.
Multi-Locus Sequence Typing (MLST)
Pacific Northwest Coast, Canada2010[85]
16PorpoiseNot reportedCryptococcus gattii—VGIIaCulture.
Multi-Locus Sequence Typing (MLST)
Pacific Northwest Coast, Canada2010[85]
17Dall’s porpoise
(Phocoenoides dalli)
Pyogranulomatous pneumonia and lymphadenitisCryptococcus gattiiNecropsyCalifornia, USA2014[89]
18California sea lion (Zalophus californianus)Systemic mycosis (skin lesions, dermal nodules, severe lymphadenopathy)Cryptococcus spp.Necropsy—combination of antibiotic (enrofloxacin, amoxicillin trihydrate-clavulanate potassium), low-dose steroid (prednisone, furosemide), anti-inflammatory (carprofren), oral diphenhydramine, itraconazole and voriconazole. Growth of Escherichia coli.USA2012[84]
19Juvenile Californian sea lion (Zalophus californianus)Pneumonia with concurrent fungal and bacterial infectionCryptococcus albidusNecropsyCalifornia, USA2009[82]
20Young (3 weeks) harbor seal (Phoca vitulina)Systemic cryptococcosis: generalized lymphadenopathy, bronchopneumonia, meningoencephalitis, fungemiaCryptococcus gattii—VGIIaNecropsyVancouver Island, Canada2016[87]
21DolphinNot reportedCryptococcus gattii—VGICulture.
Multi-Locus Sequence Typing (MLST)
Pacific Northwest Coast, Canada2010[85]
22DolphinNot reportedCryptococcus gattii—VGICulture.
Multi-Locus Sequence Typing (MLST)
Pacific Northwest Coast, Canada2010[85]
23DolphinNot reportedCryptococcus gattii—VGICulture.
Multi-Locus Sequence Typing (MLST)
Pacific Northwest Coast, Canada2010[85]
2422× living harbor seals (Phoca vitulina), juvenileNot reportedNasal swabs (19×) and lung culture (3×) negative for Cryptococcus spp.CultureVancouver Island, CanadaBetween February and August 2004[50]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Danesi, P.; Falcaro, C.; Schmertmann, L.J.; de Miranda, L.H.M.; Krockenberger, M.; Malik, R. Cryptococcus in Wildlife and Free-Living Mammals. J. Fungi 2021, 7, 29. https://doi.org/10.3390/jof7010029

AMA Style

Danesi P, Falcaro C, Schmertmann LJ, de Miranda LHM, Krockenberger M, Malik R. Cryptococcus in Wildlife and Free-Living Mammals. Journal of Fungi. 2021; 7(1):29. https://doi.org/10.3390/jof7010029

Chicago/Turabian Style

Danesi, Patrizia, Christian Falcaro, Laura J. Schmertmann, Luisa Helena Monteiro de Miranda, Mark Krockenberger, and Richard Malik. 2021. "Cryptococcus in Wildlife and Free-Living Mammals" Journal of Fungi 7, no. 1: 29. https://doi.org/10.3390/jof7010029

APA Style

Danesi, P., Falcaro, C., Schmertmann, L. J., de Miranda, L. H. M., Krockenberger, M., & Malik, R. (2021). Cryptococcus in Wildlife and Free-Living Mammals. Journal of Fungi, 7(1), 29. https://doi.org/10.3390/jof7010029

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop